Cosmix by the Numbers: What Marico Gets in Its Latest D2C Acquisition

Why It Matters

The acquisition signals FMCG giants’ accelerating shift toward online‑native, high‑margin health brands, giving Marico a fast‑growing revenue stream and deeper foothold in the premium supplement market.

Key Takeaways

• Marico buys 60% of Cosmix for undisclosed sum.
• Cosmix FY25 revenue rose to ₹50.93 cr, profit ₹8.21 cr.
• Advertising spend doubled, now 34% of total costs.
• EBITDA margin reached 22.5% with ROCE near 100%.
• Acquisition expands Marico’s D2C health‑supplement portfolio.

Pulse Analysis

Marico’s latest move reflects a broader strategic realignment among Indian FMCG leaders, who are increasingly targeting digitally native brands to capture the fast‑growing health‑and‑wellness segment. By securing a majority stake in Cosmix, Marico not only diversifies its product mix but also gains immediate access to a brand that has demonstrated consistent top‑line growth and profitability—attributes that many pure‑play D2C startups struggle to achieve. This acquisition complements Marico’s recent purchase of 4700BC, creating synergies across supply chain, marketing, and distribution channels that can accelerate scale.

Cosmix’s financial profile makes it an attractive addition. Revenue more than doubled year‑on‑year to ₹50.93 crore, while profit surged to ₹8.21 crore, delivering an EBITDA margin of 22.5% and a ROCE close to 100%. Advertising, the largest expense, rose to 34% of total spend but remained proportional to revenue growth, indicating disciplined spend management. The company’s bootstrapped nature and strong cash position (₹4.69 crore) further reduce integration risk, allowing Marico to leverage its extensive logistics and retail network without over‑capitalising the business.

Looking ahead, the success of the Cosmix deal will hinge on Marico’s ability to preserve the startup’s agility while providing the resources needed for rapid expansion. If managed well, Cosmix could serve as a launchpad for new product innovations and cross‑selling opportunities across Marico’s existing D2C brands. Conversely, excessive bureaucratic constraints could dampen the entrepreneurial spirit that drove Cosmix’s growth. The acquisition therefore exemplifies the delicate balance FMCG conglomerates must strike as they integrate nimble digital‑first players into traditional corporate structures.